3don MSN
AI trade stalls, 'ghost job' listings, Trump floats tariff rebate checks and more in Morning Squawk
CoreWeave shares plunged more than 16% after delays at a third-party data center developer weighed on full-year guidance. CEO ...
Detailed price information for Morningstar Inc (MORN-Q) from The Globe and Mail including charting and trades.
There is no denying that tech giant Microsoft ($MSFT) made a name for itself in artificial intelligence (AI), but a lot of ...
Wheat futures are mixed so far on Tuesday morning, with the winter wheats slipping lower and spring wheat higher. The wheat ...
Third quarter revenue increased 98% from the previous quarter and increased 38% from the prior year quarter; Alpha team prepares to return to flight; SciTec acquisition closes Blue Ghost Mission 2 ...
Xanadu Quantum Technologies will go public on the Nasdaq through a merger with blank-check firm Crane Harbor Acquisition Corp in a US$3.6 billion deal, the companies announced on Monday.
U.S. defense firm Anduril Industries on Friday (October 31) opened a new manufacturing facility in Sydney to produce undersea drones known as “Ghost Sharks” and deliver on its A$1.7 billion ($1.1 ...
Additionally, estimates regarding the impact of AI continue to ratchet higher. The adoption of generative AI could add as much as $15.7 trillion to the global economy by 2030, according to Big Four ...
The Canadian Press on MSN
Ghost job postings can be hard to spot but there are signs. Should you still apply?
You tailored your cover letter to the job listing, polished your resumé and completed a long online form to apply for a job — only to find out later that the company never had any intention of filling ...
Meta Platforms, Inc. is well-positioned to dominate the social media industry in the long term by its AI investments. Read ...
Oh, it’s shaping up to be one of those clunker days when the “I told you so” crowd comes out swinging, basking in the glow of ...
Denmark's Novo Nordisk launched a rival bid for U.S. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer as the drugmakers jostled for advantage in the highly lucrative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results